- Home
- TLSA vs PETS Comparison
TLSA vs PETS Comparison
Compare TLSA & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSA | PETS |
|---|---|---|
| Founded | 2013 | 1996 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail-Drug Stores and Proprietary Stores |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 206.8M | 57.8M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLSA | PETS |
|---|---|---|
| Price | $1.79 | $1.76 |
| Analyst Decision | | Sell |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $3.20 |
| AVG Volume (30 Days) | 190.6K | ★ 213.7K |
| Earning Date | 01-01-0001 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $226,972,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $2.98 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $1.59 |
| 52 Week High | $2.60 | $6.85 |
Technical Indicators
Market Signals| Indicator | TLSA | PETS |
|---|---|---|
| Relative Strength Index (RSI) | 49.38 | 35.09 |
| Support Level | $1.66 | $1.93 |
| Resistance Level | $1.83 | $2.92 |
| Average True Range (ATR) | 0.13 | 0.17 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 73.99 | 12.03 |
Price Performance
Historical ComparisonAbout TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.